K. Zeidler

Nivolumab for recurrent cutaneous squamous cell carcinoma: three cases

S. Hofer, S. Aebi, J. Diebold, 2018, European Journal of Dermatology.

Targeting RET in Patients With RET-Rearranged Lung Cancers: Results From the Global, Multicenter RET Registry.

Ross Camidge, Vamsidhar Velcheti, Thomas Filleron, 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Epstein–Barr viral load in whole blood of adults with posttransplant lymphoproliferative disorder after solid organ transplantation does not correlate with clinical course

B. Dörken, B. Gärtner, P. Reinke, 2006, Annals of Hematology.

Angiosarcoma of the scalp responding to nivolumab: a case report

S. Hofer, S. Aebi, D. Zimmermann, 2018, The British journal of dermatology.

Effect of Anti‐CD 20 Antibody Rituximab in Patients with Post‐Transplant Lymphoproliferative Disorder (PTLD)

B. Dörken, P. Reinke, N. Babel, 2005, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Optimal preprocedural platelet transfusion threshold for central venous catheter insertions in patients with thrombocytopenia

O. Senn, G. Stussi, U. Schanz, 2011, Transfusion.

Monotherapy with the anti-CD20 antibody rituximab (ritux) in patients with post-transplant lympho-proliferative disease (PTLD). Results of a multicentre phase II study.

U. Jaeger, M. Hallek, P. Reinke, 2002 .

Overall survival and role of programmed death ligand 1 expression in patients with metastatic non-small-cell lung cancer and immunotherapy: an observational study from central Switzerland.

J. Diebold, M. Dressler, O. Gautschi, 2023, Swiss medical weekly.